Sex differences in drug- and non-drug-induced analgesia

Life Sciences ◽  
2003 ◽  
Vol 72 (24) ◽  
pp. 2675-2688 ◽  
Author(s):  
Rebecca M Craft
Keyword(s):  
2021 ◽  
Vol 22 (15) ◽  
pp. 8111
Author(s):  
Kuang-Hsu Lien ◽  
Chao-Hui Yang

The triad of noise-generated, drug-induced, and age-related hearing loss is the major cause of acquired sensorineural hearing loss (ASNHL) in modern society. Although these three forms of hearing loss display similar underlying mechanisms, detailed studies have revealed the presence of sex differences in the auditory system both in human and animal models of ASNHL. However, the sexual dimorphism of hearing varies among noise-induced hearing loss (NIHL), ototoxicity, and age-related hearing loss (ARHL). Importantly, estrogen may play an essential role in modulating the pathophysiological mechanisms in the cochlea and several reports have shown that the effects of hormone replacement therapy on hearing loss are complex. This review will summarize the clinical features of sex differences in ASNHL, compare the animal investigations of cochlear sexual dimorphism in response to the three insults, and address how estrogen affects the auditory organ at molecular levels.


2021 ◽  
Vol 12 ◽  
Author(s):  
Mathias Peirlinck ◽  
Francisco Sahli Costabal ◽  
Ellen Kuhl

The electrical activity in the heart varies significantly between men and women and results in a sex-specific response to drugs. Recent evidence suggests that women are more than twice as likely as men to develop drug-induced arrhythmia with potentially fatal consequences. Yet, the sex-specific differences in drug-induced arrhythmogenesis remain poorly understood. Here we integrate multiscale modeling and machine learning to gain mechanistic insight into the sex-specific origin of drug-induced cardiac arrhythmia at differing drug concentrations. To quantify critical drug concentrations in male and female hearts, we identify the most important ion channels that trigger male and female arrhythmogenesis, and create and train a sex-specific multi-fidelity arrhythmogenic risk classifier. Our study reveals that sex differences in ion channel activity, tissue conductivity, and heart dimensions trigger longer QT-intervals in women than in men. We quantify the critical drug concentration for dofetilide, a high risk drug, to be seven times lower for women than for men. Our results emphasize the importance of including sex as an independent biological variable in risk assessment during drug development. Acknowledging and understanding sex differences in drug safety evaluation is critical when developing novel therapeutic treatments on a personalized basis. The general trends of this study have significant implications on the development of safe and efficacious new drugs and the prescription of existing drugs in combination with other drugs.


Author(s):  
Weida Tong ◽  
Qiang Shi ◽  
William Salminen ◽  
Minjun Chen ◽  
Hong Fang ◽  
...  

2015 ◽  
Vol 48 (6) ◽  
pp. 1081-1087 ◽  
Author(s):  
Jose Vicente ◽  
Lars Johannesen ◽  
Jay W. Mason ◽  
Esther Pueyo ◽  
Norman Stockbridge ◽  
...  

1981 ◽  
Vol 223 (1) ◽  
pp. 229-234 ◽  
Author(s):  
Clifford A. Brass ◽  
Stanley D. Glick
Keyword(s):  

2000 ◽  
Vol 166 (1) ◽  
pp. 163-171 ◽  
Author(s):  
B Burgi ◽  
W Lichtensteiger ◽  
M Schlumpf

Peripheral benzodiazepine (BDZ) receptor (PBR) and diazepam-binding inhibitor/acyl-CoA-binding protein (DBI/ACBP) characterized as a ligand at central BDZ receptors, at PBR with involvement in the regulation of steroidogenesis, and as an intracellular acyl-CoA transporter, are both known to interact with BDZ in adult systems. We investigated their expression after prenatal exposure to BDZ. Diazepam (1.25 mg/kg per day s.c.) was administered to time-pregnant Long Evans rats from gestational day (GD) 14 to 20. Expression of mRNAs encoding for PBR and for DBI/ACBP was studied in the same animals with (33)P-labeled 60 mer oligonucleotides (oligos) by in situ hybridization at GD20, and with (32)P-labeled oligos by Northern blot in steroidogenic and immune organs at postnatal day (PN) 14 and in adult offspring. Prenatal diazepam increased DBI/ACBP mRNA expression in male fetal adrenal and in fetal and PN14 testis. Thymus exhibited increased DBI/ACBP mRNA in male fetuses and in adult female offspring, and reduced organ weight at PN14 in both sexes. In female spleen, an increase in DBI/ACBP mRNA and a decrease in PBR mRNA was seen at PN14. Apart from the finding in spleen, no drug-induced changes in PBR mRNA were observed. The effects of prenatal diazepam were superimposed on treatment-independent sex differences in DBI/ACBP mRNA and PBR mRNA expression. Our data indicate that expression of DBI/ACBP mRNA in steroidogenic and immune organs can be affected by exposure to BDZ during ontogeny, while PBR mRNA expression appears to be less sensitive. They further reveal marked sex differences in the developmental patterns of the two proteins during pre- and postpubertal ontogeny.


Author(s):  
Joy Simpson ◽  
Colin Ryan ◽  
Anita Curley ◽  
Jeffrey Mulcaire ◽  
John P. Kelly

2020 ◽  
Vol 105 ◽  
pp. 106768
Author(s):  
Marci Harter ◽  
Jill A. Dalton ◽  
David V. Gauvin ◽  
Michael J. Caruso ◽  
Brian W. Wilson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document